Please login to the form below

Not currently logged in
Email:
Password:

INC Research promotes Susan Akers-Smith to senior oncology role

She takes up the position of VP of early phase oncology development

Contract research organisation (CRO) INC Research has promoted Susan Akers-Smith to VP of early phase oncology development.

She joined the CRO in 2004, holding a series of oncology-focused roles and serving most recently as executive director of clinical development in oncology.

Nicholas Kenny, executive VP and general manager, global oncology and haematology at INC Research, said: "We are thrilled to recognise Susan's individual efforts, creativity and performance through this well-deserved promotion.

"We always strive to combine operational efficiency with the latest advancements in medical and regulatory knowledge to conduct cancer trials of the highest quality. Susan epitomises the leadership traits necessary for this role and we look forward to leveraging her experience to further support the growing early phase oncology research needs of our customers."

Akers-Smith brings to her new role more than a decade of management experience in the CRO industry focused on early phase oncology development, with therapeutic experience including a broad range of study designs and tumour types.

Prior to working in the CRO industry, she worked in emergency healthcare and served in the US Army Reserve.

6th September 2012

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...

Infographics